# Soligenix Inc. (NASDAQ: SNGX) Closes Multimillion-Dollar Public Offering to Fund Pipeline Through 2026

* The closing of the public offering provides the company with critical financial flexibility as it continues to advance its pipeline of products.
* The $7.5 million raised through the public offering is particularly significant in the context of Soligenix’s ongoing clinical development programs.
* SNGX notes multiple potential value drivers over the next 18 months, including clinical milestones, regulatory interactions and data readouts across its pipeline.

 Soligenix (NASDAQ: SNGX) recently announced the closing of a $7.5 million public offering, providing the company with additional capital to advance its pipeline (https://ibn.fm/tCsub). This funding extends Soligenix’s cash runway through the end of 2026, ensuring that the company has the financial resources to reach key inflection points across its portfolio, including late-stage clinical trials and regulatory milestones. The move underscores Soligenix’s commitment to advancing therapies for rare diseases where there is significant unmet medical need.

 The successful closing of the public offering provides Soligenix, a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases, with critical financial flexibility as it continues to advance its pipeline of orphan and fast-track designated…

 Read More>>

 NOTE TO INVESTORS: The latest news and updates relating to SNGX are available in the company’s newsroom at https://ibn.fm/SNGX

 About BioMedWire

 BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

 BMW is where breaking news, insightful content and actionable information converge.

 To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

 For more information, please visit https://www.BioMedWire.com

 Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

 BioMedWireSan Francisco, CAwww.BioMedWire.com415.949.5050 OfficeEditor@BioMedWire.com

 BioMedWire is powered by IBN 

---

[Original/Source Press Release](https://rss.investorbrandnetwork.com/bmw/soligenix-inc-nasdaq-sngx-closes-multimillion-dollar-public-offering-to-fund-pipeline-through-2026/)
                    

[Newsramp.com TLDR](https://newsramp.com/curated-news/soligenix-secures-7-5m-funding-to-advance-rare-disease-pipeline-through-2026/3af084166c59bfc300a5527c47970130) 


Pickup - [https://burstable.news/news](https://burstable.news/news/202510/250554-soligenix-secures-7-5-million-in-public-offering-to-advance-rare-disease-pipeline-through-2026)

Pickup - [https://estallarnoticias.com/](https://estallarnoticias.com//202510/250560-soligenix-asegura-financiamiento-hasta-2026-con-oferta-publica-de-75-millones-de-dolares)

Pickup - [https://platzennachrichten.de/nachrichten](https://platzennachrichten.de/nachrichten/202510/250635-soligenix-inc-schliesst-millionen-dollar-borsenangebot-zur-finanzierung-der-pipeline-bis-2026-ab)

Pickup - [https://actueclair.com](https://actueclair.com/202510/250624-soligenix-finalise-une-offre-publique-de-75-millions-de-dollars-pour-financer-son-pipeline-jusqu-en-2026)
 

 



![Blockchain Registration](https://cdn.newsramp.app/ibn/qrcode/2510/13/rubyGAfC.webp)